Director of Judy and Bernard Briskin Center for Multiple Myeloma
City of Hope Comprehensive Cancer Center
Duarte, California
Dr. Krishnan has successfully grown the City of Hope multiple myeloma program to be the largest in southern California, with approaching 500 new patients seen per year, and has led the development of a large, diverse clinical trial portfolio of more than 15 active Phase I/II trials for all phases of multiple myeloma, now under the auspices of our recently established Judy and Bernard Briskin Center for Multiple Myeloma. She has worked to establish a strong preclinical translational program in myeloma, including our own myeloma CAR T cell program, and has led several unique trials with antibody directed therapy. On a national level, Dr. Krishnan is also the former multiple myeloma chair of the BMT CTN and current member of the CTN myeloma team, and served as national co PI of three large transplantation studies including the current SWOG/CTN trial of daratumumab/lenalidomide versus lenalidomide maintenance with an MRD-directed treatment strategy. She has been a long-standing member of the education committee, and now the current co-chair, for the Transplantation & Cellular Therapy Meetings. At the American Society of Hematology, Dr. Krishnan has belonged to the communications committee for several years. Lastly, here at City of Hope, one of the nation’s largest transplantation centers, she was a director of the BMT fellowship program for an extended time.